STAT - Reporting from the frontiers of health and medicine

In the Lab

First Opinion

By Emma Thomas

In the Lab

By STAT staff

First Opinion 11-country survey of primary care physicians shows where U.S. is lagging and keeping pace
Politics With new trade deal, Trump deals a blow to drug makers
First Opinion Do large pharma companies provide drug development innovation? Our analysis says no
Politics What’s real — and what’s illusion — in drug pricing legislation on Capitol Hill
First Opinion Mental health and addiction care are poorly covered by insurance networks

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

In tight Massachusetts job market, it’s relo for biotech and remote for tech hires
GAO finds ongoing problems with FDA inspections of foreign drug facilities
Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’

Health

Health

Health

Health

Don't Miss

By STAT

Special Report

First Opinion Do large pharma companies provide drug development innovation? Our analysis says no
In the Lab Research using brains-in-a-dish forces a radical rethinking of Huntington’s disease
First Opinion I thought patriarchy in science was fading. Then I saw it in the data
Don't Miss ‘You keep loving each other’: A window into dementia at the end of a lifelong partnership
First Opinion Name the much-criticized federal program that has saved the U.S. $2.3 trillion. Hint: it starts with Affordable